Cytokinetics(CYTK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYTK Cytokinetics

休市中 07-11 16:00:00 EDT

37.01

+0.42

+1.15%

盘后37.10

+0.09+0.24%

19:45 EDT

最高37.06	最低35.78	成交量96.07万
今开36.04	昨收36.59	日振幅3.48%
总市值44.20亿	流通市值43.98亿	总股本1.19亿
成交额3,537万	换手率0.81%	流通股本1.19亿
市净率-16.59	ROE-572.15%	每股收益-5.30
52周最高61.38	52周最低29.31	市盈率-6.99
股息0.00	股息收益率0.00	ROA-34.12%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYTK","market":"US","secType":"STK","nameCN":"Cytokinetics","latestPrice":37.01,"timestamp":1752264000000,"preClose":36.59,"halted":0,"volume":960689,"hourTrading":{"tag":"盘后","latestPrice":37.1,"preClose":37.01,"latestTime":"19:45 EDT","volume":30167,"amount":1116443.129,"timestamp":1752277512861},"delay":0,"floatShares":118837453,"shares":119427293,"eps":-5.298384,"marketStatus":"休市中","change":0.42,"latestTime":"07-11 16:00:00 EDT","open":36.04,"high":37.055,"low":35.78,"amount":35368126.754064,"amplitude":0.034846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.298384,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1083211200000,"exchange":"NASDAQ","adjPreClose":36.59,"preHourTrading":{"tag":"盘前","latestPrice":36.01,"preClose":36.59,"latestTime":"09:29 EDT","volume":1481,"amount":53433.65064,"timestamp":1752240599999},"postHourTrading":{"tag":"盘后","latestPrice":37.1,"preClose":37.01,"latestTime":"19:45 EDT","volume":30167,"amount":1116443.129,"timestamp":1752277512861},"volumeRatio":0.605874941543355,"impliedVol":0.5506,"impliedVolPercentile":0.12},"requestUrl":"/m/hq/s/CYTK","defaultTab":"news","newsList":[{"id":"2550655742","title":"Cytokinetics, Incorporated盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550655742?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:24","pubTimestamp":1752071044,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时24分，Cytokinetics, Incorporated股票出现异动，股价大幅拉升5.05%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为1.29%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709222404a4408f66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709222404a4408f66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","CYTK","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2542336147","title":"小摩：维持Cytokinetics(CYTK.US)评级，由增持调整至增持评级, 目标价由71.00美元调整至53.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542336147","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542336147?lang=zh_cn&edition=full","pubTime":"2025-06-09 23:54","pubTimestamp":1749484488,"startTime":"0","endTime":"0","summary":"小摩：维持Cytokinetics(CYTK.US)评级，由增持调整至增持评级, 目标价由71.00美元调整至53.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/09235450957649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CYTK"],"gpt_icon":0},{"id":"2539671602","title":"瑞穗银行：维持Cytokinetics评级，由优于大市调整至优于大市评级, 目标价由103.00美元调整至84.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539671602","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539671602?lang=zh_cn&edition=full","pubTime":"2025-05-30 00:31","pubTimestamp":1748536293,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Cytokinetics(CYTK.US)评级，由优于大市调整至优于大市评级, 目标价由103.00美元调整至84.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530003414950721cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530003414950721cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTK"],"gpt_icon":0},{"id":"2537647114","title":"Cytokinetics, Incorporated盘中异动 下午盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537647114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537647114?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:04","pubTimestamp":1747764262,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时04分，Cytokinetics, Incorporated股票出现波动，股价快速拉升5.04%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为0.89%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020422a6e659a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020422a6e659a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","CYTK","BK4588"],"gpt_icon":0},{"id":"2536343799","title":"Cytokinetics, Incorporated盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536343799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536343799?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:46","pubTimestamp":1747414008,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日00时46分，Cytokinetics, Incorporated股票出现异动，股价快速上涨5.04%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为4879.95%、2933.78%、1438.71%，振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.，振幅分别为466.98%、66.89%、66.82%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051700464994f92dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051700464994f92dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","CYTK","BK4139","BK4585","BK4505"],"gpt_icon":0},{"id":"1175650490","title":"异动解读 | Cytokinetics股价盘中大跌5.01%，心脏病药物研究达主要目标却未能提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1175650490","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175650490?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:53","pubTimestamp":1747378439,"startTime":"0","endTime":"0","summary":"生物制药公司Cytokinetics周二盘中股价大跌5.01%，引发市场关注。这一跌势与公司刚刚公布的积极消息形成鲜明对比，该公司宣布其试验性心脏病药物在一项后期研究中已达到主要目标。尽管公司传出利好消息，但投资者似乎并未对此作出积极反应。作为一家专注于肌肉生物学的生物制药公司，Cytokinetics的这款心脏病药物的成功对公司未来发展至关重要。然而，从当前股价走势来看，市场似乎对公司前景持谨慎态度。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CYTK"],"gpt_icon":0},{"id":"1118875737","title":"异动解读 | 心脏病药物试验成功，Cytokinetics盘前大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118875737","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118875737?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:53","pubTimestamp":1747378382,"startTime":"0","endTime":"0","summary":"生物制药公司Cytokinetics（CYTK）周二盘前股价大涨5.01%，引起投资者广泛关注。\n\n根据路透社报道，Cytokinetics公司于5月13日宣布，其试验性心脏病药物在一项后期研究中达到了主要目标。这一积极的研究结果是推动公司股价大幅上涨的主要原因。\n\n后期临床试验的成功对于制药公司来说至关重要，因为它为药物获得监管机构批准和最终商业化铺平了道路。虽然公司尚未公布详细的试验数据，但这一结果无疑增强了投资者对Cytokinetics未来发展前景的信心。如果该心脏病药物最终获得批准并成功上市，将可能为公司带来可观的收入增长，从而进一步提升其在生物制药行业的地位。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CYTK"],"gpt_icon":0},{"id":"1131370405","title":"异动解读 | Cytokinetics股价盘中大跌5.01%，心脏病药物研究达主要目标却未能提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1131370405","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131370405?lang=zh_cn&edition=full","pubTime":"2025-05-13 22:36","pubTimestamp":1747147003,"startTime":"0","endTime":"0","summary":"生物制药公司Cytokinetics周二盘中股价大跌5.01%，引发市场关注。这一跌势与公司刚刚公布的积极消息形成鲜明对比，该公司宣布其试验性心脏病药物在一项后期研究中已达到主要目标。尽管公司传出利好消息，但投资者似乎并未对此作出积极反应。作为一家专注于肌肉生物学的生物制药公司，Cytokinetics的这款心脏病药物的成功对公司未来发展至关重要。然而，从当前股价走势来看，市场似乎对公司前景持谨慎态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CYTK"],"gpt_icon":0},{"id":"1146063011","title":"异动解读 | 心脏病药物试验成功，Cytokinetics盘前大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146063011","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146063011?lang=zh_cn&edition=full","pubTime":"2025-05-13 19:42","pubTimestamp":1747136542,"startTime":"0","endTime":"0","summary":"生物制药公司Cytokinetics（CYTK）周二盘前股价大涨5.01%，引起投资者广泛关注。\n\n根据路透社报道，Cytokinetics公司于5月13日宣布，其试验性心脏病药物在一项后期研究中达到了主要目标。这一积极的研究结果是推动公司股价大幅上涨的主要原因。\n\n后期临床试验的成功对于制药公司来说至关重要，因为它为药物获得监管机构批准和最终商业化铺平了道路。虽然公司尚未公布详细的试验数据，但这一结果无疑增强了投资者对Cytokinetics未来发展前景的信心。如果该心脏病药物最终获得批准并成功上市，将可能为公司带来可观的收入增长，从而进一步提升其在生物制药行业的地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"异动解读 | 心脏病药物试验成功，Cytokinetics盘前大涨5.01%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CYTK"],"gpt_icon":0},{"id":"2534279911","title":"Cytokinetics, Incorporated盘中异动 早盘快速拉升5.06%报33.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534279911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534279911?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:40","pubTimestamp":1747057247,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时40分，Cytokinetics, Incorporated股票出现波动，股价快速拉升5.06%。截至发稿，该股报33.30美元/股，成交量9.9915万股，换手率0.08%，振幅4.91%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为2.71%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214047a6dc530a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214047a6dc530a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","CYTK","BK4588"],"gpt_icon":0},{"id":"2533955348","title":"花旗：维持Cytokinetics(CYTK.US)评级，由买入调整至买入评级, 目标价由86.00美元调整至80.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533955348","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533955348?lang=zh_cn&edition=full","pubTime":"2025-05-07 23:57","pubTimestamp":1746633462,"startTime":"0","endTime":"0","summary":"花旗：维持Cytokinetics(CYTK.US)评级，由买入调整至买入评级, 目标价由86.00美元调整至80.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07235750208758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CYTK"],"gpt_icon":0},{"id":"1173957632","title":"异动解读 | Cytokinetics股价盘后大涨5.94%，营收超预期增长89.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173957632","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173957632?lang=zh_cn&edition=full","pubTime":"2025-05-07 05:57","pubTimestamp":1746568621,"startTime":"0","endTime":"0","summary":"生物技术公司Cytokinetics周二盘后股价大涨5.94%，主要受益于该公司公布的第一季度财报中营收数据远超分析师预期。根据公司发布的财报，截至3月31日的季度内，Cytokinetics实现营收158万美元，同比大幅增长89.1%，远超分析师预期的120万美元。值得注意的是，尽管Cytokinetics过去几个季度的盈利表现未达预期，但华尔街分析师对公司前景仍保持乐观态度。分析师给予Cytokinetics未来12个月的目标价中位数为75.00美元，显示出对公司长期发展的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Cytokinetics股价盘后大涨5.94%，营收超预期增长89.1%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CYTK"],"gpt_icon":0},{"id":"2532180562","title":"瑞银：维持Cytokinetics评级，由中性调整至中性评级, 目标价由47.00美元调整至41.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532180562","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532180562?lang=zh_cn&edition=full","pubTime":"2025-05-03 07:04","pubTimestamp":1746227087,"startTime":"0","endTime":"0","summary":"瑞银：维持Cytokinetics(CYTK.US)评级，由中性调整至中性评级, 目标价由47.00美元调整至41.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050307074694eb098a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050307074694eb098a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTK"],"gpt_icon":0},{"id":"2532844192","title":"Cytokinetics, Incorporated盘中异动 大幅跳水14.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532844192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532844192?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:32","pubTimestamp":1746192737,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时32分，Cytokinetics, Incorporated股票出现波动，股价快速下跌14.95%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为1.33%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213217a6d11cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213217a6d11cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTK","BK4505","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2532069915","title":"Cytokinetics, Incorporated盘中异动 下午盘大幅上涨5.03%报43.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532069915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532069915?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:37","pubTimestamp":1746034660,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日01时37分，Cytokinetics, Incorporated股票出现异动，股价大幅拉升5.03%。截至发稿，该股报43.37美元/股，成交量71.2449万股，换手率0.60%，振幅6.76%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为1.38%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501013740aa2c8009&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501013740aa2c8009&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4505","CYTK","BK4139"],"gpt_icon":0},{"id":"2529568223","title":"Cytokinetics, Incorporated盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529568223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529568223?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:49","pubTimestamp":1745416148,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时49分，Cytokinetics, Incorporated股票出现波动，股价大幅上涨5.00%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为1.03%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214908a463ff45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214908a463ff45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4585","CYTK","BK4588"],"gpt_icon":0},{"id":"2529339473","title":"Cytokinetics, Incorporated盘中异动 快速下跌5.04%报37.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529339473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529339473?lang=zh_cn&edition=full","pubTime":"2025-04-22 02:06","pubTimestamp":1745258771,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日02时06分，Cytokinetics, Incorporated股票出现异动，股价急速下跌5.04%。截至发稿，该股报37.49美元/股，成交量109.715万股，换手率0.92%，振幅4.39%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体跌幅为1.08%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家后期生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422020611973fa505&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422020611973fa505&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4585","CYTK","BK4588","BK4139"],"gpt_icon":0},{"id":"2517301014","title":"Cytokinetics, Incorporated2024财年实现净利润-5.90亿美元，同比减少12.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517301014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517301014?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363247,"startTime":"0","endTime":"0","summary":"3月8日，Cytokinetics, Incorporated公布财报，公告显示公司2024财年净利润为-5.90亿美元，同比减少12.17%；其中营业收入为18.47百万美元，同比增加145.29%，每股基本收益为-5.26美元。从资产负债表来看，Cytokinetics, Incorporated总负债15.37亿美元，其中短期债务30.50百万美元，资产负债比为0.92，流动比率为6.16。机构评级：截至2025年3月8日，当前有20家机构对Cytokinetics, Incorporated目标价做出预测，其中目标均价为79.30美元，其中最低目标价为60.00美元，最高目标价为120.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000202a2647f1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000202a2647f1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYTK"],"gpt_icon":0},{"id":"2516652859","title":"Cytokinetics, Incorporated盘中异动 下午盘股价大跌5.11%报43.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652859?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:25","pubTimestamp":1741026329,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时25分，Cytokinetics, Incorporated股票出现异动，股价快速跳水5.11%。截至发稿，该股报43.65美元/股，成交量75.1047万股，换手率0.63%，振幅6.13%。Cytokinetics, Incorporated股票所在的生物技术行业中，整体涨幅为0.16%。Cytokinetics, Incorporated公司简介：细胞动力科技有限公司是一家生物技术公司，开发肌肉生物学驱动的治疗以肌肉功能降低、肌肉无力和疲劳为特征的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022529a25d8339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022529a25d8339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4585","BK4588","CYTK","BK4139"],"gpt_icon":0},{"id":"1110517708","title":"Cytokinetics 2024年第四季度GAAP每股收益$(1.26)，低于$(1.17)的预期，销售额为1692.7万美元，高于预计的174.2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110517708","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110517708?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:10","pubTimestamp":1740690631,"startTime":"0","endTime":"0","summary":"Cytokinetics  公布季度亏损为每股$，低于分析师的一致预期$，相差7.69%。公司报告季度销售额为1692.7万美元，远高于分析师一致预期的174.2万美元，超过了871.94%。这一结果较去年同期167.2万美元的销售额增长了912.38%。以上内容来自Benzinga Earnings专栏，原文如下：$Cytokinetics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 7.69 percent. This is a 8.7 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $16.927 million which beat the analyst consensus estimate of $1.742 million by 871.94 p","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cytokinetics 2024年第四季度GAAP每股收益$(1.26)，低于$(1.17)的预期，销售额为1692.7万美元，高于预计的174.2万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYTK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytokinetics.com","stockEarnings":[{"period":"1week","weight":0.0678},{"period":"1month","weight":0.1178},{"period":"3month","weight":-0.0424},{"period":"6month","weight":-0.2061},{"period":"1year","weight":-0.3426},{"period":"ytd","weight":-0.2132}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cytokinetics, Incorporated于1997年8月5日成立，符合特拉华州的法律规定。它是一家处于临床阶段的生物制药公司，主要致力于为重大疾病和糟糕的医疗条件提供潜在的治疗方法的这样一种调节肌肉功能的新型小分子治疗方法的发现和发展。它目前处于发展阶段，着重于科研，开发药品筛选技术和融资。","yearOnYearQuotes":[{"month":1,"riseRate":0.47619,"avgChangeRate":0.002524},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.024236},{"month":3,"riseRate":0.47619,"avgChangeRate":-0.003116},{"month":4,"riseRate":0.619048,"avgChangeRate":0.016608},{"month":5,"riseRate":0.590909,"avgChangeRate":0.01979},{"month":6,"riseRate":0.409091,"avgChangeRate":-0.000087},{"month":7,"riseRate":0.681818,"avgChangeRate":0.059491},{"month":8,"riseRate":0.666667,"avgChangeRate":0.045334},{"month":9,"riseRate":0.380952,"avgChangeRate":0.009349},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.081654},{"month":11,"riseRate":0.47619,"avgChangeRate":0.018926},{"month":12,"riseRate":0.47619,"avgChangeRate":0.104126}],"exchange":"NASDAQ","name":"Cytokinetics","nameEN":"Cytokinetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cytokinetics(CYTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cytokinetics(CYTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cytokinetics,CYTK,Cytokinetics股票,Cytokinetics股票老虎,Cytokinetics股票老虎国际,Cytokinetics行情,Cytokinetics股票行情,Cytokinetics股价,Cytokinetics股市,Cytokinetics股票价格,Cytokinetics股票交易,Cytokinetics股票购买,Cytokinetics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cytokinetics(CYTK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cytokinetics(CYTK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}